Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30066602HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066603HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066604HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066605HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066606HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066607HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066608HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066609HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS30066610HIVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20041820HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TCGA Plot Options
Drug Information
GeneAHR
DrugBank IDDB01097
Drug NameLeflunomide
Target IDBE0003721
UniProt IDP35869
Regulation Typeagonist
PubMed IDs20957046; 17327465
CitationsO'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK: The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One. 2010 Oct 1;5(10). pii: e13128. doi: 10.1371/journal.pone.0013128.@@Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR: Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol. 2007 Jun;71(6):1475-86. Epub 2007 Feb 27.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Pathways
PharmGKBPA450192
ChEMBLCHEMBL960